Condition: Dilated Cardiomyopathy · Kaposi's Sarcoma-Associated Herpesvirus Infection · Sponsor: Tongji Hospital
Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.
This description comes directly from the study's public registry record.
Yanru Zhao, Doctor · 86-027-83663280 · zyrecho@163.com
Always discuss trial participation with your own doctor first.
| Tongji Hospital | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06236022